Guidelines for Stability Testing of Pediatric Drug Products
1) Purpose
The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for addressing the specific stability testing requirements for pediatric drug products in accordance with relevant regulatory guidelines. This SOP ensures that stability data supports the quality, safety, and efficacy of pediatric drug products throughout their intended shelf life.
2) Scope
This SOP applies to all personnel involved in the design, execution, and documentation of stability studies for pediatric drug products intended for global markets.
3) Responsibilities
Stability Testing Team: Responsible for conducting stability studies and documenting results in compliance with regulatory guidelines specific to pediatric drug products.
Quality Assurance (QA) Team: Responsible for reviewing and approving stability study protocols and reports.
Regulatory Affairs Team: Responsible for ensuring that stability studies meet the regulatory expectations for pediatric products.
4) Procedure
4.1 Preparation for Stability Testing
4.1.1
4.1.2 Develop a stability protocol specific to pediatric formulations, including study design, testing schedule, storage conditions, and testing parameters.
4.2 Selection of Batches and Samples
4.2.1 Select representative batches of the pediatric drug product, typically three primary batches manufactured using the
4.2.2 Prepare sufficient samples to cover the entire study duration, considering the number of time points and tests to be conducted.
4.3 Defining Storage Conditions and Time Points
4.3.1 Define the storage conditions according to regulatory guidelines, considering specific factors such as pediatric formulations’ stability and excipient compatibility.
4.3.2 Establish the time points for sampling, such as 0, 3, 6, 9, 12, 18, and 24 months for long-term studies, and additional time points for accelerated studies.
4.4 Conducting Stability Tests
4.4.1 Store samples under the defined conditions, monitoring temperature and humidity to ensure compliance with the set parameters.
4.4.2 At each specified time point, remove samples and conduct stability-indicating tests, including physical, chemical, microbiological, and functional tests, as applicable.
4.4.3 Record all results meticulously in stability data sheets, ensuring accuracy and traceability of data.
5) Abbreviations, if any
QA: Quality Assurance
RH: Relative Humidity
6) Documents, if any
Stability protocol, stability data sheets, stability testing records, stability report, submission package to regulatory authorities.
7) Reference, if any
Regulatory Guidelines for Stability Testing of Pediatric Drug Products (FDA, EMA, WHO, etc.).
8) SOP Version
Version 1.0